$EL

Estée Lauder (NYSE:EL) surprises with Q3 CY2026 sales

Estée Lauder reported Q3 CY2026 revenue of $3.72 billion, beating estimates by 1.8% and growing 6.8% year-on-year. Adjusted EPS of $0.72 exceeded expectations by 41.9%. Operating margin improved to 11% from 4.9% last year, while free cash flow was -$235 million, an improvement from -$436 million. Organic revenue rose 6% year-on-year, and full-year adjusted EPS guidance was in line with expectations.

Original reporting
Published Nov 2, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 11:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Estée Lauder (NYSE:EL) surprises with Q3 CY2026 sales — source image
Decision brief

The 30-second read

$ELBullishHigh
01

Why it matters

The earnings beat and margin expansion are likely to drive short-term price appreciation.

02

Market read

Earnings surprise is a primary catalyst for immediate trading decisions.

03

What to watch

Free cash flow remains negative, which could temper enthusiasm.

Relevance 9/10Novelty 9/10Timing: after-hours today

Background

Estée Lauder's Q3 earnings release provides fresh financial data for the company.

Company-level read

Ticker impact

$ELBullishHigh confidence
Context

Estée Lauder reported Q3 CY2026 revenue of $3.72B vs $3.65B estimate and adjusted EPS $0.72 vs $0.51 estimate, beating both.

Expected impact

likely upward pressure as market prices in the earnings beat

Evidence & confidence

Revenue and EPS beat expectations; margin expansion indicates stronger profitability.

Market effects

Beauty and cosmetics sector may see broader rally on strong earnings.

U.S. consumer discretionary stocks could benefit.

Limited to markets tracking U.S. consumer stocks.

Counterpoint

If guidance remains in line, the beat may be priced in, limiting upside.

Key entities

  • Estée Lauder Companies Inc.

    U.S.-listed beauty and cosmetics conglomerate.

Related articles

$ELHighAI 8/10

The Estee Lauder Companies Inc (EL) (Q1 2027) Earnings Call Highlights: Broad-Based

Estee Lauder (EL) reported Q1 2027 organic sales up 6%, raising its full-year outlook. Growth was broad-based, with fragrance up 20%. The company expects softer net sales growth in H2 due to tougher comparisons and reduced innovation. Margins may be pressured by commodity and freight inflation. EL is gaining market share in China and the US, with a focus on volume share. The One ELC operating model aims to improve efficiency and growth.

$ELHighAI 8/10

Estée Lauder (EL) Q1 2027 Earnings Call Transcript

Estée Lauder (EL) reported Q1 2027 sales growth of 7% (6% organic), raising its fiscal 2027 outlook. Organic sales growth is now expected at 4% to 5.5%, up from 3% to 5%. Operating margin expansion is forecasted at 170 to 250 basis points, up from 150 to 230. Fragrance sales rose 20%, with strong performance from Le Labo, TOM FORD, and KILIAN PARIS. All regions and categories saw growth, with Asia Pacific leading. The company is investing in consumer-facing initiatives and innovation.

$ELMedAI 8/10

Estee Lauder earnings analysis: questions answered and next catalysts

Estee Lauder (EL) reported fiscal Q1 2027 earnings, beating estimates with adjusted EPS of $0.72 and revenue of $3.72B. Shares initially rose but later fell. Management raised guidance for sales, EPS, and operating margins. Analysts note strong growth in all regions, but some concerns remain about valuation and earnings quality. Key catalysts include the holiday quarter and China retail trends.

$ELMedAI 8/10

What Estee Lauder Companies (EL) Said on Its Q1 Earnings Call

Estee Lauder (EL) reported Q1 earnings, highlighting 20% organic sales growth in fragrance, led by brands like Le Labo and TOM FORD. Skincare and makeup also saw growth, while hair care stabilized. China and priority emerging markets drove regional growth. The company raised its fiscal 2027 outlook, expecting 4% to 5.5% organic net sales growth and improved operating margins.